The most common (>20%) adverse reactions, including laboratory abnormalities, were increased phosphate, nail disorders, stomatitis, diarrhea, increased creatinine, increased alkaline phosphatase, increased alanine aminotransferase, decreased hemoglobin, decreased sodium, increased aspartate aminotransferase, fatigue, dry mouth, dry skin, decreased phosphate, decreased appetite, dysgeusia, constipation, increased calcium, dry eye, palmar-plantar erythrodysesthesia syndrome, increased potassium, alopecia, and central serous retinopathy.
from FDA,2024.01
Balversa is an innovative targeted therapy drug that is clinically used in patie···【more】
Release date:2024-08-27Recommended:128
Balversa is currently a new star in the field of anti-cancer, which is used oral···【more】
Release date:2024-08-27Recommended:128
Balversa is a new oral anti-cancer star on the market, showing excellent tumor s···【more】
Release date:2024-08-27Recommended:120